scholarly article | Q13442814 |
P50 | author | Fiona Watt | Q5451129 |
P2093 | author name string | J M Carroll | |
V Cattell | |||
J P Seery | |||
P2860 | cites work | Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules | Q24317179 |
Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology | Q29618865 | ||
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180 | Q33908707 | ||
Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus | Q34199681 | ||
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. | Q34657104 | ||
Concepts of pathogenesis of systemic lupus erythematosus | Q36140631 | ||
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains | Q36342054 | ||
The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice | Q36352533 | ||
In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon | Q36353914 | ||
Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. | Q36364415 | ||
Mechanisms of cytokine-mediated localized immunoprotection | Q36367596 | ||
Direct and indirect control of T-cell activation by keratinocytes | Q40402651 | ||
Pathomechanisms of photosensitive lupus erythematosus | Q40707994 | ||
Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins | Q40782682 | ||
An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate | Q40880683 | ||
The skin immune system: progress in cutaneous biology | Q40883468 | ||
Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. | Q41759956 | ||
Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse | Q42032820 | ||
Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour | Q42099573 | ||
Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma | Q43576523 | ||
In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse | Q46838308 | ||
Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients | Q56909047 | ||
Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis | Q57222363 | ||
Transgenic Mice Expressing IFN-γ in the Epidermis Have Eczema, Hair Hypopigmentation, and Hair Loss | Q57385102 | ||
Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification | Q67370394 | ||
Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis | Q67815725 | ||
Systemic lupus erythematosus | Q71046919 | ||
Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses | Q71197083 | ||
Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients | Q71634765 | ||
Impact of ultraviolet radiation on the cellular expression of Ro/SS-A-autoantigenic polypeptides | Q72104394 | ||
Regulation of pemphigus and desmosomal antigen expression by keratinocyte differentiation | Q72104401 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoantibody | Q785022 |
lupus nephritis | Q1621830 | ||
P304 | page(s) | 1451-1459 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis | |
P478 | volume | 186 |
Q47593368 | Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells |
Q64102174 | Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target |
Q40960280 | Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis: effects of suprabasal integrin expression on keratinocyte adhesion, proliferation and terminal differentiation |
Q34451949 | Anticytokine gene therapy of autoimmune diseases |
Q35557370 | Autoimmune aspects of cytokine and anticytokine therapies |
Q43725027 | Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies |
Q36863150 | B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. |
Q37320550 | Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus |
Q37944412 | Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models |
Q99634936 | Complement Properdin Determines Disease Activity in MRL/lpr Mice |
Q33973488 | Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy |
Q36659210 | Cytokines in systemic lupus erythematosus |
Q37405187 | Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin |
Q35086727 | Dendritic cells under investigation in autoimmune disease |
Q36536967 | Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice |
Q46066180 | Effector and predisposing genes in murine lupus |
Q36373291 | Epidermal injury promotes nephritis flare in lupus-prone mice |
Q39136252 | Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses |
Q54194029 | From the Cover: Interplay Between IFN-γ and IL-6 Impacts the Inflammatory Response and Expression of Interferon-Regulated Genes in Environmental-Induced Autoimmunity. |
Q35661227 | Genetic basis of murine lupus. |
Q35997885 | Genetically modified mice as a tool to study inflammatory skin diseases |
Q36593309 | Genetics of SLE in mice |
Q36054813 | Genetics of lupus nephritis |
Q33893349 | Genetics of systemic lupus erythematosus. Clinical implications |
Q37114935 | Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid |
Q34105647 | IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice |
Q24805092 | IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus? |
Q35675526 | Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor |
Q28212039 | Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus |
Q62111834 | Interferon-γ polymorphisms in systemic lupus erythematosus |
Q36079852 | Interferons as pathogenic effectors in autoimmunity |
Q38446765 | Langerhans cells are required for UVR-induced immunosuppression |
Q37721150 | Langerhans cells: critical regulators of skin immunity? |
Q26822662 | Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus |
Q35675523 | Links between type I interferons and the genetic basis of disease in mouse lupus. |
Q35045888 | Many paths lead to lupus. |
Q33816779 | NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery |
Q35984223 | Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species |
Q42509581 | Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity |
Q37224188 | Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling |
Q37902251 | Recent advances in cytokines in cutaneous and systemic lupus erythematosus |
Q60595376 | Sensitization of IFN-γ Jak-STAT signaling during macrophage activation |
Q51743751 | Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. |
Q56897860 | Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice |
Q79073423 | Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity |
Q44299579 | T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients |
Q44586207 | T-bet as a possible therapeutic target in autoimmune disease |
Q37243790 | T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction |
Q35235610 | TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity |
Q55059074 | Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice. |
Q42214549 | Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α. |
Q47134266 | The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases |
Q28244375 | The construction of transgenic and gene knockout/knockin mouse models of human disease |
Q64964840 | The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity. |
Q37706192 | The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases. |
Q51137468 | The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors |
Q24805385 | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
Q33367867 | The role of endothelial cell apoptosis in inflammatory and immune diseases |
Q34731092 | Therapy of systemic lupus erythematosus: a look into the future |
Q35045906 | Transgenic models of tolerance and autoimmunity: with special reference to systemic lupus erythematosus |
Q33331412 | Use of laser microdissection in the analysis of renal-infiltrating T cells in MRL/lpr mice |
Search more.